Molecular Profiling Identifies Targeted Therapy Opportunities in Pediatric Solid Cancer - Episode Sponsored by Osteosarcoma Institute episode artwork

EPISODE · Jul 10, 2022 · 1H 1M

Molecular Profiling Identifies Targeted Therapy Opportunities in Pediatric Solid Cancer - Episode Sponsored by Osteosarcoma Institute

from MIB Agents OsteoBites and osTEAo · host MIB Agents Osteosarcoma

This episode is sponsored by the Osteosarcoma Institute (OSI), a nonprofit organization led by osteosarcoma experts from top U.S. cancer centers who, together, are concentrating on the cure ® for osteosarcoma. The mission of the OSI is to dramatically increase treatment options and survival rates in osteosarcoma patients through identifying and funding the most promising and breakthrough osteosarcoma clinical trials and science. In addition to advancing research, OSI also provides a free resource called OSI Connect for osteosarcoma patients. Our osteosarcoma experts can discuss available treatments, possible side effects, and provide helpful advice for getting the most out of your visits with your treating physician. This resource is available in English and Spanish and aims to help patients and families find answers to their questions. Join us for OsteoBites with Dr. Alanna Church from Boston Children's Hospital. She will discuss the study recently published in Nature Medicine with Dr. Katie Janeway and many other collaborators, demonstrating the clinical utility of molecular tumor profiling for children with cancer. This cohort includes 345 children and AYA cancer patients from 12 institutions who had molecular tumor profiling using targeted NGS panels, including 64 patients with osteosarcoma. Molecular alterations with potential impact on the diagnosis, prognosis or treatment were identified in 86% of patients.​ She hopes these results will help to advocate for molecular profiling for all children with cancer. Read the paper here: https://rdcu.be/cQgmj Reminder that this July for Sarcoma Awareness month, join us for our Virtual OutRunning OsteoSarcoma event! When you run/walk/cycle with us, you can help Cause A Cure. With MIB, no one walks through Osteosarcoma alone - let’s go OutRunning together! Register at: https://mibagents.swoogo.com/OutRunning Also to commemorate Sarcoma Awareness Month, MIB is partnering with Kendra Scott for a Multi-City give back event taking place the weekend July 15-17! By making a purchase during this weekend, you are helping raise funds and awareness for Osteosarcoma. This September, we encourage you to Be Bold and Go Gold for Childhood Cancer Awareness Month! Make & Sell Bows in your community OR Make a donation this summer and get a bow that shows you care. Contact [email protected] to volunteer today!

Episode metadata supplied by the publisher feed · Published Jul 10, 2022

Embed this episode

NOW PLAYING

Molecular Profiling Identifies Targeted Therapy Opportunities in Pediatric Solid Cancer - Episode Sponsored by Osteosarcoma Institute

0:00 1:01:12

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MIB Agents OsteoBites and osTEAo?

This episode is 1 hour and 1 minute long.

When was this MIB Agents OsteoBites and osTEAo episode published?

This episode was published on July 10, 2022.

Can I download this MIB Agents OsteoBites and osTEAo episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!